Concepedia

G. Anilkumar

GA

Statistics

Publications

15

Citations

433

H-Index

13

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ligand Pharmaceuticals (United States)

North Carolina State University

Swarthmore College

G. Anilkumar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1998–2012

15

Publications

15

Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis

Soo Min, Yuanfan Wang, Waldemar Gonsiorek et al. · Biochemical and Biophysical Research Communications · 2009 · 60 citations

, , +14

CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis

Yuanfan Wang, Long Cui, Waldemar Gonsiorek et al. · Journal of Inflammation · 2009 · 55 citations · Full text

, , +17

I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles

G. Anilkumar, Charles A. Lesburg, Oleg Selyutin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 49 citations

, , +14

Targeted Glycosyl Donor Delivery for Site-Selective Glycosylation<sup>,</sup><sup>1</sup>

G. Anilkumar, Latha G. Nair, Bert Fraser‐Reid · Organic Letters · 2000 · 42 citations

, , +17

Structure–Activity Relationship (SAR) Development and Discovery of Potent Indole-Based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase

Kevin X. Chen, Bancha Vibulbhan, Weiying Yang et al. · Journal of Medicinal Chemistry · 2011 · 30 citations · Full text

, , +17

1–5 of 15